Gaudium IVF
BSE: GAUDIUMIVF · Healthcare Service Provider
Snapshot
Unlock Gaudium IVF's vital signs
Growth · Profitability · Valuation · Strength · Conviction
Company Overview
Business
Gaudium IVF and Women Health Limited is a healthcare provider specialising in Assisted Reproductive Technology (ART) and In Vitro Fertilization (IVF) treatments. The company operates a network of over 30 facilities across India, utilising a hub-and-spoke model alongside a dedicated day-care hospital and in-house pharmacy services.
Business Model
The company generates revenue through the provision of specialised fertility treatments and clinical consultations across its hub-and-spoke network. Additional income streams are derived from its 15-bed day-care hospital and pharmaceutical sales through its wholly owned subsidiary.
- Hub locations:7
- Spoke locations:28
- Hospital capacity:15 beds
Growth Outlook
Growth is expected to be driven by the expansion of the hub-and-spoke network and the increasing demand for fertility services in India. The company continues to leverage its integrated model to capture market share in the specialised reproductive healthcare segment.
Key Risks
- Regulatory Risk. The IVF and ART sector is subject to stringent government regulations and evolving licensing requirements that could impact operational continuity.
- Competitive Intensity. The fertility healthcare market in India is highly fragmented with increasing competition from both large hospital chains and specialised boutique clinics.
- Operational Dependency. Success is heavily dependent on the retention of highly skilled medical professionals and embryologists, whose departure could affect service quality.
- Economic Sensitivity. As IVF treatments are often elective and high-cost, demand may be sensitive to fluctuations in disposable income and general economic conditions.
Price
Start your research today
Unlock AI insights, financials, peers and live data on Gaudium IVF and 5,000+ companies — free.
Peers · Healthcare Service Provider
| Company | Mkt Cap (Cr) | P/E | EV/EBITDA | Rev Gr YoY | EBITDA Mgn | ROE | ROCE | 1Y Return |
|---|---|---|---|---|---|---|---|---|
Gaudium IVFGAUDIUMIVF | 569 | — | — | — | 36.0% | — | — | — |
Thyrocare Technologies Ltd.THYROCARE | 5,857 | 24.86 | 9.89 | 20.6% | 33.7% | 29.3% | 36.5% | -56.0% |
Nephrocare Health ServicesNEPHROPLUS | 5,259 | — | — | — | 22.0% | — | — | — |
Krsnaa Diagnostics Ltd.KRSNAA | 1,832 | 17.47 | 8.92 | 7.8% | 33.0% | 11.2% | 14.7% | -34.5% |
Suraksha Diagnostic Ltd.SURAKSHA | 1,318 | 41.25 | 13.66 | — | 32.1% | 14.7% | 18.4% | -19.9% |
3B Blackbio3BBLACKBIO | 1,064 | 18.14 | 12.67 | 41.9% | 58.0% | 21.2% | 26.3% | -19.9% |
As of Mar 2026
Financials
Gaudium IVF
BSE: GAUDIUMIVF · Healthcare Service Provider
Snapshot
Unlock Gaudium IVF's vital signs
Growth · Profitability · Valuation · Strength · Conviction
Company Overview
Business
Gaudium IVF and Women Health Limited is a healthcare provider specialising in Assisted Reproductive Technology (ART) and In Vitro Fertilization (IVF) treatments. The company operates a network of over 30 facilities across India, utilising a hub-and-spoke model alongside a dedicated day-care hospital and in-house pharmacy services.
Business Model
The company generates revenue through the provision of specialised fertility treatments and clinical consultations across its hub-and-spoke network. Additional income streams are derived from its 15-bed day-care hospital and pharmaceutical sales through its wholly owned subsidiary.
- Hub locations:7
- Spoke locations:28
- Hospital capacity:15 beds
Growth Outlook
Growth is expected to be driven by the expansion of the hub-and-spoke network and the increasing demand for fertility services in India. The company continues to leverage its integrated model to capture market share in the specialised reproductive healthcare segment.
Key Risks
- Regulatory Risk. The IVF and ART sector is subject to stringent government regulations and evolving licensing requirements that could impact operational continuity.
- Competitive Intensity. The fertility healthcare market in India is highly fragmented with increasing competition from both large hospital chains and specialised boutique clinics.
- Operational Dependency. Success is heavily dependent on the retention of highly skilled medical professionals and embryologists, whose departure could affect service quality.
- Economic Sensitivity. As IVF treatments are often elective and high-cost, demand may be sensitive to fluctuations in disposable income and general economic conditions.
Price
Loading…
Start your research today
Unlock AI insights, financials, peers and live data on Gaudium IVF and 5,000+ companies — free.
Peers · Healthcare Service Provider
As of Mar 2026